CIK 0001521036 · Large accelerated filer
Lantheus Holdings, Inc.
Sign in to watch- Ticker
- LNTH
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 352318913
- Phone
- 978 671-8001
- Business address
- 201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
- Former names
- Lantheus MI Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-03 | Niedzwiecki Daniel See Remarks | Grant or award | +10,514 | 88,258 | ||
| 2025-03-03 | Niedzwiecki Daniel See Remarks | Shares withheld for taxes | −12,907 | $94.86 | $1.2M | 75,351 |
| 2025-03-03 | Marshall Robert J. Jr. CFO and Treasurer | Grant or award | +17,274 | 120,237 | ||
| 2025-03-03 | Marshall Robert J. Jr. CFO and Treasurer | Shares withheld for taxes | −20,261 | $94.86 | $1.9M | 99,976 |
| 2025-03-03 | MARKISON BRIAN A CEO | Shares withheld for taxes | −8,637 | $94.86 | $819K | 161,511 |
| 2025-03-03 | Blanchfield Paul President | Grant or award | +13,769 | 110,506 | ||
| 2025-03-03 | Blanchfield Paul President | Shares withheld for taxes | −16,594 | $94.86 | $1.6M | 93,912 |
| 2025-03-03 | Heino Mary Anne Director | Grant or award 10b5-1 | +50,070 | 493,506 | ||
| 2025-03-03 | Heino Mary Anne Director | Sale 10b5-1 | −6,265 | $92.29 | $578K | 487,241 |
| 2025-03-03 | Heino Mary Anne Director | Sale 10b5-1 | −9,160 | $93.32 | $855K | 478,081 |
| 2025-03-03 | Heino Mary Anne Director | Sale 10b5-1 | −15,017 | $94.09 | $1.4M | 463,064 |
| 2025-03-03 | Heino Mary Anne Director | Sale 10b5-1 | −17,694 | $95.40 | $1.7M | 445,370 |
| 2025-03-03 | Heino Mary Anne Director | Sale 10b5-1 | −4,971 | $95.91 | $477K | 440,399 |
| 2025-03-03 | Morgan Amanda Michelle Chief Commercial Officer | Shares withheld for taxes | −759 | $94.86 | $72K | 24,652 |
| 2025-02-07 | Morrow Phuong Khanh Director | Grant or award · Stock Option (right to buy) | +1,015 | 1,015 | ||
| 2025-02-07 | Morrow Phuong Khanh Director | Grant or award | +563 | 563 | ||
| 2025-02-07 | Morrow Phuong Khanh Director | Grant or award · Stock Option (right to buy) | +1,017 | 1,017 | ||
| 2025-01-15 | Thrall James H Director | Sale 10b5-1 | −1,000 | $94.76 | $95K | 33,207 |
| 2024-12-19 | MARKISON BRIAN A CEO | Option exercise | +16,102 | $12.42 | $200K | 168,928 |
| 2024-12-19 | MARKISON BRIAN A CEO | Option exercise | +16,666 | $6.00 | $100K | 185,594 |
Page 6 of 9 · 177 trades